1. Adjuvant tyrosine kinase inhibitor therapy improves outcome for children and adolescents with acute lymphoblastic leukaemia who have an ABL‐class fusion. (14th September 2020) Authors: Moorman, Anthony V.; Schwab, Claire; Winterman, Emily; Hancock, Jerry; Castleton, Anna; Cummins, Michelle; Gibson, Brenda; Goulden, Nick; Kearns, Pam; James, Beki; Kirkwood, Amy A.; Lancaster, Donna; Madi, Mabrouk; McMillan, Andrew; Motwani, Jayashree; Norton, Alice; O'Marcaigh, Aengus; Patrick, ... Journal: British journal of haematology Issue: Volume 191:Number 5(2020) Page Start: 844 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗